Office of Biotechnology Activities    National Institutes of Health - Office of Science Policy   RAC December 6, 2002 - Presentation Materials Day 3 Bethesda, Maryland Discussion of Human Gene Transfer Protocol #0208-550 entitled     A Phase I/II Study of an Antitumor Vaccination Using (1,3) Galactosyltransferase Expressing Allogeneic Tumor Cells in Patients With Relapsed or Refractory Breast Cancer     Roscoe F. Morton, M.D., Stoddard Cancer Research Institute, Iowa Methodist Medical Center     Slides     ADJOURN     Top of Page

6705 Rockledge Drive, Suite 750, MSC 7985 Bethesda, MD 20892-7985 (For all non-USPS mail, please use ZIP code 20817) Phone: 301-496-9838, Fax: 301-496-9839 E-mail OBA at oba@od.nih.gov

RDNA324